Katarina Brzica

Dr. Katarina Brzica

Klinički Bolnički Centar Split, Split, Splitsko-Dalmatinska Županija, Croatia
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2022 in Genes
Verified
Journal Article
Open access
PDF file
KBKatarina Brzica
Katarina Brzica
MSMarko Simunovic
Marko Simunovic
MIMatea Ivancic
Matea Ivancic
DTDarija Tudor
Darija Tudor
ISIvna Skrabic
Ivna Skrabic
VSVeselin Skrabic
Veselin Skrabic
Background: McCune-Albright is a rare syndrome, caused by mutation of the GNAS1 gene, and is characterized by an appearance of multiple endocrinopathies, most commonly premature puberty, polyostotic fibrous dysplasia and skin changes called cafe au lait macules. Case report: We present the case of a patient who is, to the best of our knowledge and after extensive review of literature, the youngest McCune-Albright syndrome patient with growth hormone excess, diagnosed at 8.9 months of age. An extensive diagnostic procedure was done upon the diagnosis. Hormonal assessment was performed and all hormone levels were within reference range, and an additional oral glucose suppression that noted the presence of growth hormone excess. Magnetic resonance imaging of the pituitary gland did not detect a tumor process. The genetic analysis of the GNAS1 gene from skin punch biopsy came back negative. Octreotide was administered as therapy for growth hormone excess at 9.8 months. After the introduction of therapy, we noted a decrease in growth rate from 29.38 to 16.6 cm/year. Conclusion: This case report emphasizes the lack of available data on treatment of growth hormone excess and follow-up in pediatric population and the need for further research.

6 October 2022 in Radiology Case Reports
Verified
Journal Article
Open access
MRMarijana Rogulj
Marijana Rogulj
KBKatarina Brzica
Katarina Brzica
MIMatea Ivancic
Matea Ivancic
ARAngela Renic
Angela Renic
Beaver tail liver is an anatomical liver variant presenting as elongated left lobe of liver which extends laterally to the spleen. It can present with symptoms or be detected accidentally. We present a case of a 2-year-old asymptomatic patient who was had an X-ray of the chest describing a shadow of unknown origin located left paracardial and the diagnosis of “beaver tail liver” was confirmed after a multi-slice computed tomography of thorax and abdomen was done. We give an overview of very sparse available literature on this anatomical variant while emphasizing the rarity of diagnosis in pediatric population and clinical importance of this variant.

27 July 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
APAntonia Pavlović
Antonia Pavlović
AMAntonija Miljak
Antonija Miljak
KBKatarina Brzica
Katarina Brzica
MDMerica Glavina Durdov
Merica Glavina Durdov
Thymic regulatory lymphocytes (Tregs) are rare in the normal periphery where they mediate immune tolerance but accumulate in the tumor immune microenvironment (TIM), reducing the antitumor response. Subtypes of classical Hodgkin lymphoma (CHL) are characterized by a minority of malignant Hodgkin and Reed–Sternberg cells (HRS) and an abundant TIM that plays a key role in modulating the disease. CHL is related to the Epstein–Barr virus (EBV), whose oncogenes influence the growth of HRS. We analyzed the number of T lymphocytes expressing the regulatory marker FOXP3 in CHL with regard to EBV status. The tumor tissue of 182 patients was stained by double immunohistochemistry for FOXP3, CD4, and CD8, and the number of different phenotypes was analyzed microscopically. EBV status was determined by EBER in situ hybridization. EBV-positive CHL was confirmed in 28% of patients and was associated with mixed cellularity (MC) (p < 0.001), older age (p < 0.001), and unfavorable outcomes (p = 0.038). The number of CD8+ T lymphocytes differed according to the EBV status of MC and nodular sclerosis (NS), and was the lowest in EBV-negative NS (p = 0.001). Likewise, the numbers for FOXP3 and FOXP3/CD4 were different, and were the lowest in EBV-negative MC (p = 0.035 and p = 0.041, respectively). Values above a median of FOXP3 and CD4 are associated with longer progression-free survival (p = 0.039 and p < 0.001, respectively). EBV impacts the composition of T cell phenotypes in TIM, among which the amount of CD4 and FOXP3 is prognostically valuable.